Latest Conference Articles

Victoria Garcia Albea, NP, discussed safety monitoring, patient selection, and laboratory screening considerations for oral JAK inhibitors at Elevate-Derm summer 2026

Catch Up on Coverage From Day 2 of the 3rd Annual Elevate-Derm Summer Conference

Elevate-Derm expert panel offers practical JAK inhibitor pearls on cholesterol, comorbid autoimmune disease, and shared decision-making.

At Elevate Derm, Lisa Swanson, MD, discussed earlier oral JAK inhibitor use for alopecia areata and selecting appropriate patients.

RAD 2026 experts unpacked new IL-13, JAK, STAT6 and OX40 options, CHE and pediatric gaps, plus overlooked comorbidities shaping AD care.

At Elevate-Derm, Justin Love, PA-C, urged clinicians to pair diagnostic expertise with emotional intelligence and thoughtful investigation.

San Diego meeting highlights inflammatory dermatoses, skin cancer, alopecia, and emerging therapeutic advances

Catch Up on Coverage From Day 1 of the 3rd Annual Elevate-Derm Summer Conference

Linda Stein Gold, MD, presents tapinarof cream as a long-term, nonsteroidal option for pediatric atopic dermatitis based on data presented at the 2026 Society for Pediatric Dermatology Annual Meeting.

Learn from Adnan Mir, MD, PhD, on how better biopsies and direct lab communication help APPs and dermatopathologists boost pediatric skin diagnoses and outcomes.

Lawrence Eichenfield, MD, presented phase 3 results showing lebrikizumab boosts skin clearance, eases itch, and looks safe for infants through teens with moderate to severe atopic dermatitis.

A panel at SPD 2026 emphasized how pediatric dermatologists tackle pay gaps using RVU benchmarks, private practice options, and coding tactics to raise reimbursement.

Live from SPD 2026; learn how dermatologists can spot teen body dysmorphia, avoid reassurance traps, and use quick in-clinic tools to trigger early mental health referral.

Pediatric vitiligo care now prioritizes comorbidity screening like thyroid checks and anemia evaluation, mental health support, and new therapies including JAK trials and phototherapy options.

Linda Stein Gold, MD, discusses pooled phase 3 tapinarof cream data across pediatric atopic dermatitis age groups presented at the 2026 Society for Pediatric Dermatology meeting.

Pediatric histiocytosis updates at SPD 2026 reveal BRAF/MEK targets as dermatopathology and biopsy genetics boost accuracy in complex childhood dermatoses.

Honored with a top pediatric dermatology award, Amy Paller, MD, MS, shares her mentorship roots, career highlights, and continued advocacy for new treatments and research.

Sarah Chamlin, MD, and Jonathan Dyer, MD, shared practical guidance on treating ulcerated infantile hemangiomas and assessing café-au-lait spots, emphasizing pain control, propranolol, follow-up, and genetics.

In his session at SPD, Markus Boos, MD, PhD showed how inclusive language, privacy, and team training improve dermatologic care and outcomes for gender minority youth.

Nanette Silverberg, MD, shares new pediatric vitiligo guidance, spotlighting facial-first goals, topicals, UVB, and steroid "rescue" strategies for widespread, fast-moving disease.

At SPD 2026, Brandi Kenner-Bell, MD, FAAD, shared practical pediatric dermatology tips for curly and coily hair: cleanse smarter, deep condition, avoid damaging chemicals, and reduce braid tension to prevent breakage.

Pediatric dermatology experts will gather in Minneapolis for SPD's Annual Meeting: will you be there?

Real-world TARGET-DERM data show switching to upadacitinib boosts skin clearance, itch relief and quality of life for tough atopic dermatitis.

LEADderm, led by Jennifer Soung, MD, helps dermatologists build leadership, AI readiness, and purpose-driven careers—leaving attendees energized, connected, and patient-focused.

Explore top dermatology conferences and meetings in July 2026 and let us know which ones you'll be attending!

Lim considers mentoring and helping develop the next generation of dermatologists one of his most meaningful contributions to the specialty.

Raj Chovatiya, MD, PhD, MSCI, co-chair of RAD 2026, highlighted new AD science, type 2 inflammation insights, and emerging therapies—helping clinicians translate immunology advances into better patient care.

Expert guidance from RAD 2026 dispels eczema diet myths, urging symptom-based allergy testing and whole-patient atopic dermatitis care with practical skin, sleep, and lifestyle strategies.